| Name | Cvs Pharmacy #16493 |
|---|---|
| Organization Name | Ohio Cvs Stores Llc |
| Location | 2490 N Fairfield Rd, Beavercreek, Ohio 45431 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (937) 431-8672 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) stating that Regis passed the FDA's pre-approval inspection (PAI) for its manufacture of 4-Aminopyridine the active ingredient in Ampyra™.
BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.
Researchers from Charité - Universitätsmedizin Berlin have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson's disease.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.
› Verified 5 days ago
| NPI Number | 1023030731 |
| Organization Name | OHIO CVS STORES LLC |
| Doing Business As | CVS PHARMACY # |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2490 N Fairfield Rd, Beavercreek, OH 45431 |
| Phone Number | 937-431-8672 |
News Archive
Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) stating that Regis passed the FDA's pre-approval inspection (PAI) for its manufacture of 4-Aminopyridine the active ingredient in Ampyra™.
BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.
Researchers from Charité - Universitätsmedizin Berlin have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson's disease.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.
› Verified 5 days ago
News Archive
Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) stating that Regis passed the FDA's pre-approval inspection (PAI) for its manufacture of 4-Aminopyridine the active ingredient in Ampyra™.
BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.
Researchers from Charité - Universitätsmedizin Berlin have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson's disease.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.
› Verified 5 days ago
Cvs Pharmacy #03458 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1331 North Fairfield Rd, Beavercreek, Ohio 45432 Phone: (937) 426-4478 | |
Cvs Pharmacy #16493 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2490 N Fairfield Rd, Beavercreek, Ohio 45431 Phone: (937) 431-8672 | |
Sams Pharmacy # 10 6517 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3446 Pentagon Blvd, Beavercreek, Ohio 45431 Phone: (937) 427-0879 | |
Kroger Pharmacy #14-811 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3165 Dayton-xenia Road, Beavercreek, Ohio 45434 Phone: (937) 431-8230 | |
Wal Mart Pharmacy 10-2124 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3360 Pentagon Blvd, Beavercreek, Ohio 45431 Phone: (937) 426-7007 |